Showing 1 - 10 of 612
Turnkey Communication Services launches digital verification service
Business, Komsan Tortermvasana, Published on 30/07/2025
» SET-listed Turnkey Communication Services (TKC) has launched a Thai Certificate Authority (ThaiCA) service, aiming to increase confidence in electronic transactions.
US warship arrives in Australia ahead of exercises
Published on 14/06/2025
» SYDNEY - A key US warship arrived in Australia on Saturday ahead of joint war games and the first summit between Prime Minister Anthony Albanese and President Donald Trump, which is expected to be dominated by military issues.
Novo Nordisk Thailand and HSRI MoU Enhances Clinical Research Standards
Published on 02/06/2025
» The rapid advancement of medical technology is playing a vital role in enhancing the health system and quality of life for individuals in Thailand. Clinical research is essential in facilitating the development of new medications, devices, and treatment methodologies for complex and rare diseases. Reports indicate that nations such as China, the United States, various African countries, and others in Asia are significantly increasing their investments in medical research and development (R&D). Thailand has been classified as an ‘opportunity tier’, possessing a large number of patients ready for treatment. This presents researchers with numerous opportunities for trial volunteers, making Thailand more competitive compared to Europe and the US, where research costs tend to be higher.
Thammasat, Novo Nordisk Unite for Holistic Diabetes, Obesity Care
Published on 28/05/2025
» Thammasat University Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), announced a collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity Beat Diabetes” at the Thammasat University Hospital. The public-private partnership aims to enhance holistic patient care and expand equitable access for all.
Novo Nordisk Leads Obesity Fight in Thailand
Published on 20/05/2025
» Bangkok, May 2025 – Novo Nordisk, the global pharmaceutical leader headquartered in Denmark, has launched a major initiative to combat Thailand’s growing obesity crisis, where more than 40% of the population is now classified as overweight or obese.
Novo Nordisk Launches Campaign to Tackle Obesity
Published on 20/05/2025
» Novo Nordisk Pharma (Thailand) Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the “From My Weight to My Heart” campaign, aimed at reducing the risk of cardiovascular diseases and non-communicable diseases (NCDs)—key global health challenges. The campaign debuted with an inspirational panel featuring leading public figures.
Novo Nordisk, Nanyang Launch Shoes for Haemophilia Awareness
Published on 08/05/2025
» Bangkok, Thailand – 6 May 2025 – Novo Nordisk Pharma (Thailand) Ltd. (Novo Nordisk), a global healthcare company committed to driving change in chronic diseases, has announced the delivery of unique shoes, produced in collaboration with renowned Thai shoe manufacturer Nanyang, to the Thai Haemophilia Patient Club. The collaboration aims to enhance awareness of haemophilia in Thailand, underscoring the message of equitable access to healthcare.
Novo Nordisk Leads Danish-Thai Forum on Obesity Solutions
Published on 08/05/2025
» The Royal Danish Embassy in Thailand, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), organised the first Danish-Thai Obesity Policy Forum, bringing together top policymakers, healthcare professionals and industry representatives to discuss challenges arising from the growing prevalence of obesity and its socio-economic impacts in Thailand. The forum, titled “Obesity – A National Threat to Health and Wealth, Act Now for Our Future Generations”, featured remarks from decision-makers and a panel discussion.
Liberals ride Trump backlash to victory in Canada
Published on 29/04/2025
» OTTAWA - Canadian Prime Minister Mark Carney’s Liberals staged a major political comeback to retain power in parliamentary elections, fuelled by a backlash against US President Donald Trump’s tariffs and comments about making Canada the 51st US state.
Chulalongkorn, Novo Nordisk Partner to Tackle Obesity
Published on 05/04/2025
» Bangkok, April 2025 – Chulalongkorn University, in collaboration with Novo Nordisk Pharma (Thailand) Ltd., has officially launched “Chulalongkorn x Novo Nordisk: Enhancing Obesity Management through Innovative Collaboration” at the Rattanawithayapat Building, King Chulalongkorn Memorial Hospital. This initiative marks a significant public-private partnership aimed at improving access to reliable obesity information and promoting more effective management through digital engagement.